Feng Cai

465 total citations
28 papers, 348 citations indexed

About

Feng Cai is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology. According to data from OpenAlex, Feng Cai has authored 28 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Feng Cai's work include Pituitary Gland Disorders and Treatments (13 papers), Neuroendocrine Tumor Research Advances (3 papers) and Glioma Diagnosis and Treatment (3 papers). Feng Cai is often cited by papers focused on Pituitary Gland Disorders and Treatments (13 papers), Neuroendocrine Tumor Research Advances (3 papers) and Glioma Diagnosis and Treatment (3 papers). Feng Cai collaborates with scholars based in China, United States and Hong Kong. Feng Cai's co-authors include Xiaohai Liu, Congxin Dai, Renzhi Wang, Ming Feng, Yong Yao, Sihai Ma, Yakun Yang, Ying Zang, Tingting Qian and Guoying Zhang and has published in prestigious journals such as ACS Nano, Biomaterials and Chemical Engineering Journal.

In The Last Decade

Feng Cai

28 papers receiving 344 citations

Peers

Feng Cai
Emily Siegel United States
Hima V. Vangapandu United States
Rie Ayuzawa United States
Chiyo Doi United States
Si–Hyun Bae South Korea
Emily Siegel United States
Feng Cai
Citations per year, relative to Feng Cai Feng Cai (= 1×) peers Emily Siegel

Countries citing papers authored by Feng Cai

Since Specialization
Citations

This map shows the geographic impact of Feng Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Cai more than expected).

Fields of papers citing papers by Feng Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Cai. The network helps show where Feng Cai may publish in the future.

Co-authorship network of co-authors of Feng Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Cai. A scholar is included among the top collaborators of Feng Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Cai. Feng Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Feng, Jingyi Tang, Yifei Yang, et al.. (2025). Rationally constructing the theranostics hydrogels for targeted CT imaging and healing of inflammatory bowel disease. Chemical Engineering Journal. 513. 162986–162986. 2 indexed citations
2.
Chen, Yike, Kaikai Ding, Tianchi Tang, et al.. (2024). TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO. Journal of Experimental & Clinical Cancer Research. 43(1). 39–39. 17 indexed citations
3.
Cai, Feng, et al.. (2023). Beyond antioxidation: Harnessing the CeO2 nanoparticles as a renoprotective contrast agent for in vivo spectral CT angiography. Biomaterials. 299. 122164–122164. 16 indexed citations
4.
Zhang, Suli, Qian Sun, Feng Cai, Hui Li, & Yufu Zhou. (2022). Local therapy treatment conditions for oligometastatic non-small cell lung cancer. Frontiers in Oncology. 12. 1028132–1028132. 5 indexed citations
5.
Chen, Yike, Linkai Wang, Feng Cai, et al.. (2022). Transsphenoidal Surgery of Giant Pituitary Adenoma: Results and Experience of 239 Cases in A Single Center. Frontiers in Endocrinology. 13. 879702–879702. 20 indexed citations
6.
Xu, Hongbo, et al.. (2022). Assessing the Efficacy of a Tumor Nanovaccine and Artificial Antigen Presenting Cell-Based System as a Combination Therapy in a Mouse Model of Melanoma. Journal of Biomedical Nanotechnology. 18(5). 1362–1375. 1 indexed citations
8.
Cai, Feng, Shasha Chen, Jing Zhang, et al.. (2021). Transcription factor GTF2B regulates AIP protein expression in growth hormone-secreting pituitary adenomas and influences tumor phenotypes. Neuro-Oncology. 24(6). 925–935. 10 indexed citations
9.
Liang, Weiwei, et al.. (2020). Fluconazole for Hypercortisolism in Cushing’s Disease: A Case Report and Literature Review. Frontiers in Endocrinology. 11. 608886–608886. 2 indexed citations
10.
Cai, Feng, Congxin Dai, Shasha Chen, et al.. (2019). CXCL12-regulated miR-370–3p functions as a tumor suppressor gene by targeting HMGA2 in nonfunctional pituitary adenomas. Molecular and Cellular Endocrinology. 488. 25–35. 10 indexed citations
11.
Song, Dandan, et al.. (2018). Efficacy of surgery and prophylactic cranial irradiation in stage II and III small cell lung cancer. Journal of Cancer. 9(19). 3500–3506. 14 indexed citations
13.
Guo, Yidi, et al.. (2017). IL-8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF-κB pathway in prostate cancer. Molecular Medicine Reports. 16(6). 9035–9042. 51 indexed citations
14.
Yan, Wei, Sheng Wu, Chenhan Ling, et al.. (2015). [Pterional keyhole approach in surgical treatment of ruptured anterior circulation intracranial aneurysm: a report of 313 cases].. PubMed. 44(4). 366–70. 1 indexed citations
15.
Liu, Xiaohai, Sihai Ma, Congxin Dai, et al.. (2013). Antiproliferative, Antiinvasive, and Proapoptotic Activity of Folate Receptor α-Targeted Liposomal Doxorubicin in Nonfunctional Pituitary Adenoma Cells. Endocrinology. 154(4). 1414–1423. 17 indexed citations
16.
Dai, Congxin, Bo Zhang, Xiaohai Liu, et al.. (2013). Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways. International Journal of Cancer. 133(8). 1982–1993. 32 indexed citations
17.
Cai, Feng, Yidan Zhang, Yakun Yang, et al.. (2013). Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis. European Journal of Endocrinology. 169(6). 867–884. 21 indexed citations
18.
Liu, Xiaohai, Sihai Ma, Yong Yao, et al.. (2011). Differential Expression of Folate Receptor Alpha in Pituitary Adenomas and Its Relationship to Tumor Behavior. Neurosurgery. 70(5). 1274–1280. 18 indexed citations
19.
Yang, Wenbin, et al.. (2009). [Role of prostate stem cell antigen in human pancreatic carcinoma: a tissue microarray-based study].. PubMed. 29(10). 2135–7. 4 indexed citations
20.
Matsuyama, S, Koji Inoue, Janivette Alsina, et al.. (2000). ATPase and GTPase activities copurifying with GTP-binding proteins in E. coli.. PubMed. 2(3). 261–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026